BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23826330)

  • 1. A Novel Phosphopeptide Microarray Based Interactome Map in Breast Cancer Cells Reveals Phosphoprotein-GRB2 Cell Signaling Networks.
    Krishnamoorthy S; Liu Z; Hong A; Zhu R; Chen H; Li T; Zhou X; Gao X
    PLoS One; 2013; 8(6):e67634. PubMed ID: 23826330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression.
    Bourguignon LY; Singleton PA; Zhu H; Diedrich F
    J Biol Chem; 2003 Aug; 278(32):29420-34. PubMed ID: 12748184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphoprotein secretome of tumor cells as a source of candidates for breast cancer biomarkers in plasma.
    Zawadzka AM; Schilling B; Cusack MP; Sahu AK; Drake P; Fisher SJ; Benz CC; Gibson BW
    Mol Cell Proteomics; 2014 Apr; 13(4):1034-49. PubMed ID: 24505115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MPZL1 forms a signalling complex with GRB2 adaptor and PTPN11 phosphatase in HER2-positive breast cancer cells.
    Beigbeder A; Chartier FJM; Bisson N
    Sci Rep; 2017 Sep; 7(1):11514. PubMed ID: 28912526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Covalent Inhibition of Grb2-Sos1 Interaction through Proximity-Induced Conjugation in Breast Cancer Cells.
    Yu Y; Nie Y; Feng Q; Qu J; Wang R; Bian L; Xia J
    Mol Pharm; 2017 May; 14(5):1548-1557. PubMed ID: 28060514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dok-3 sequesters Grb2 and inhibits the Ras-Erk pathway downstream of protein-tyrosine kinases.
    Honma M; Higuchi O; Shirakata M; Yasuda T; Shibuya H; Iemura S; Natsume T; Yamanashi Y
    Genes Cells; 2006 Feb; 11(2):143-51. PubMed ID: 16436051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of major ERK-related phosphorylation sites in Gab1.
    Lehr S; Kotzka J; Avci H; Sickmann A; Meyer HE; Herkner A; Muller-Wieland D
    Biochemistry; 2004 Sep; 43(38):12133-40. PubMed ID: 15379552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling adaptor ShcD suppresses extracellular signal-regulated kinase (Erk) phosphorylation distal to the Ret and Trk neurotrophic receptors.
    Wills MK; Keyvani Chahi A; Lau HR; Tilak M; Guild BD; New LA; Lu P; Jacquet K; Meakin SO; Bisson N; Jones N
    J Biol Chem; 2017 Apr; 292(14):5748-5759. PubMed ID: 28213521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.
    Li S; Couvillon AD; Brasher BB; Van Etten RA
    EMBO J; 2001 Dec; 20(23):6793-804. PubMed ID: 11726515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory role of DOC-2/DAB2 in growth factor receptor-mediated signal cascade. DOC-2/DAB2-mediated inhibition of ERK phosphorylation via binding to Grb2.
    Zhou J; Hsieh JT
    J Biol Chem; 2001 Jul; 276(30):27793-8. PubMed ID: 11371563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple binding sites in the growth factor receptor Xmrk mediate binding to p59fyn, GRB2 and Shc.
    Wellbrock C; Schartl M
    Eur J Biochem; 1999 Feb; 260(1):275-83. PubMed ID: 10091608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine phosphorylation of Grb2: role in prolactin/epidermal growth factor cross talk in mammary epithelial cell growth and differentiation.
    Haines E; Minoo P; Feng Z; Resalatpanah N; Nie XM; Campiglio M; Alvarez L; Cocolakis E; Ridha M; Di Fulvio M; Gomez-Cambronero J; Lebrun JJ; Ali S
    Mol Cell Biol; 2009 May; 29(10):2505-20. PubMed ID: 19273609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and biophysical investigation of the interaction of a mutant Grb2 SH2 domain (W121G) with its cognate phosphopeptide.
    Papaioannou D; Geibel S; Kunze MB; Kay CW; Waksman G
    Protein Sci; 2016 Mar; 25(3):627-37. PubMed ID: 26645482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting SH2 domains in breast cancer.
    Morlacchi P; Robertson FM; Klostergaard J; McMurray JS
    Future Med Chem; 2014; 6(17):1909-26. PubMed ID: 25495984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoproteomics identifies oncogenic Ras signaling targets and their involvement in lung adenocarcinomas.
    Sudhir PR; Hsu CL; Wang MJ; Wang YT; Chen YJ; Sung TY; Hsu WL; Yang UC; Chen JY
    PLoS One; 2011; 6(5):e20199. PubMed ID: 21637843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLP-76-Cbl-Grb2-Shc interactions in FcgammaRI signaling.
    Chu J; Liu Y; Koretzky GA; Durden DL
    Blood; 1998 Sep; 92(5):1697-706. PubMed ID: 9716598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses.
    Schaeper U; Gehring NH; Fuchs KP; Sachs M; Kempkes B; Birchmeier W
    J Cell Biol; 2000 Jun; 149(7):1419-32. PubMed ID: 10871282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Grb2-mSos1 complex binds phosphopeptides with higher affinity than Grb2.
    Chook YM; Gish GD; Kay CM; Pai EF; Pawson T
    J Biol Chem; 1996 Nov; 271(48):30472-8. PubMed ID: 8940013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Novel Physiological Substrates of
    Nakedi KC; Calder B; Banerjee M; Giddey A; Nel AJM; Garnett S; Blackburn JM; Soares NC
    Mol Cell Proteomics; 2018 Jul; 17(7):1365-1377. PubMed ID: 29549130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospho-tyrosine dependent protein-protein interaction network.
    Grossmann A; Benlasfer N; Birth P; Hegele A; Wachsmuth F; Apelt L; Stelzl U
    Mol Syst Biol; 2015 Mar; 11(3):794. PubMed ID: 25814554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.